Literature DB >> 17653095

Loss of pericentromeric DNA methylation pattern in human glioblastoma is associated with altered DNA methyltransferases expression and involves the stem cell compartment.

M Fanelli1, S Caprodossi, L Ricci-Vitiani, A Porcellini, F Tomassoni-Ardori, S Amatori, F Andreoni, M Magnani, R De Maria, A Santoni, S Minucci, P G Pelicci.   

Abstract

Cancer is generally characterized by loss of CG dinucleotides methylation resulting in a global hypomethylation and the consequent genomic instability. The major contribution to the general decreased methylation levels seems to be due to demethylation of heterochromatin repetitive DNA sequences. In human immunodeficiency, centromeric instability and facial anomalies syndrome, demethylation of pericentromeric satellite 2 DNA sequences has been correlated to functional mutations of the de novo DNA methyltransferase 3b (DNMT3b), but the mechanism responsible for the hypomethylated status in tumors is poorly known. Here, we report that human glioblastoma is affected by strong hypomethylation of satellite 2 pericentromeric sequences that involves the stem cell compartment. Concomitantly with the integrity of the DNMTs coding sequences, we report aberrations in DNA methyltrasferases expression showing upregulation of the DNA methyltransferase 1 (DNMT1) and downregulation of the de novo DNA methyltransferase 3a (DNMT3a). Moreover, we show that DNMT3a is the major de novo methyltransferase expressed in normal neural progenitor cells (NPCs) and its forced re-expression is sufficient to partially recover the methylation levels of satellite 2 repeats in glioblastoma cell lines. Thus, we speculate that DNMT3a decreased expression may be involved in the early post-natal inheritance of an epigenetically altered NPC population that could be responsible for glioblastoma development later in adult life.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17653095     DOI: 10.1038/sj.onc.1210642

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  35 in total

Review 1.  Molecular epigenetics and genetics in neuro-oncology.

Authors:  Raman P Nagarajan; Joseph F Costello
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

Review 2.  Integration and analysis of genome-scale data from gliomas.

Authors:  Gregory Riddick; Howard A Fine
Journal:  Nat Rev Neurol       Date:  2011-07-05       Impact factor: 42.937

Review 3.  Epigenetic Regulation of Centromere Chromatin Stability by Dietary and Environmental Factors.

Authors:  Diego Hernández-Saavedra; Rita S Strakovsky; Patricia Ostrosky-Wegman; Yuan-Xiang Pan
Journal:  Adv Nutr       Date:  2017-11-15       Impact factor: 8.701

4.  CpG island hypermethylation in human astrocytomas.

Authors:  Xiwei Wu; Tibor A Rauch; Xueyan Zhong; William P Bennett; Farida Latif; Dietmar Krex; Gerd P Pfeifer
Journal:  Cancer Res       Date:  2010-03-16       Impact factor: 12.701

5.  DNA demethylating antineoplastic strategies: a comparative point of view.

Authors:  Stefano Amatori; Irene Bagaloni; Benedetta Donati; Mirco Fanelli
Journal:  Genes Cancer       Date:  2010-03

6.  Histone 3 lysine 9 trimethylation is differentially associated with isocitrate dehydrogenase mutations in oligodendrogliomas and high-grade astrocytomas.

Authors:  Sriram Venneti; Michelle Madden Felicella; Thomas Coyne; Joanna J Phillips; Daniel Gorovets; Jason T Huse; Julia Kofler; Chao Lu; Tarik Tihan; Lisa M Sullivan; Mariarita Santi; Alexander R Judkins; Arie Perry; Craig B Thompson
Journal:  J Neuropathol Exp Neurol       Date:  2013-04       Impact factor: 3.685

7.  Effects on biological behavior of bladder carcinoma T24 cells via silencing DNMT1 and/or DNMT3b with shRNA in vitro.

Authors:  Shilong Zhang; Fuqing Zeng; Shibo Peng; Chaohui Zhu; Heng Li; Liang Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-04-28

8.  Overexpression of DNA methyltransferase 1 (DNMT1) protein in astrocytic tumour and its correlation with O6-methylguanine-DNA methyltransferase (MGMT) expression.

Authors:  Wan Faiziah Wan Abdul Rahman; Khairul Shakir Ab Rahman; Siti Norasikin Mohd Nafi; Mohd Hashairi Fauzi; Hasnan Jaafar
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

9.  Overexpression of CDKN2B (p15INK4B) and altered global DNA methylation status in mesenchymal stem cells of high-risk myelodysplastic syndromes.

Authors:  A Poloni; G Maurizi; D Mattiucci; S Amatori; B Fogliardi; B Costantini; M Mariani; S Mancini; A Olivieri; M Fanelli; P Leoni
Journal:  Leukemia       Date:  2014-06-19       Impact factor: 11.528

Review 10.  DNA hypomethylation in cancer cells.

Authors:  Melanie Ehrlich
Journal:  Epigenomics       Date:  2009-12       Impact factor: 4.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.